
Matthieu Legrand
@matthieulegrand
Critical care doc/Intensivist & Anesthesiologist - Prof @UCSF #criticalcare #AKI #sepsis #Translational #Trials
ID: 129752360
https://anesthesia.ucsf.edu/people/matthieu-legrand 05-04-2010 08:46:02
2,2K Tweet
1,1K Followers
721 Following

āļøOur new publication on the role of RAAS and exogenous angiotensin II in sepsis with a practical algorithm for its use š What an honor to collaborate with experts in this field! š¤ Ashish K. Khanna, MD,MS,FCCP,FCCM,FASA Matthieu Legrand Jean-Louis Vincent å°č°·ē„樹 Yuki Kotaniļ½éäøę²»ēå» Intensivist Rinaldo Bellomo ccforum.biomedcentral.com/articles/10.11ā¦


SGLT2i in the ICU š« Matthieu Legrand Marlies Ostermann Intensive Care Medicine rdcu.be/d2gCK



1/ Intensive Care Medicine's latest articles: ICU toolbox Topical Collection š¹How to manage sodium-glucose cotransporter-2 inhibitors in the critically ill patient? š rdcu.be/d2maQ



Viewpoint by Richard Platt, Hayden Bosworth, and Gregory Simon discusses the challenges of implementing findings from pragmatic clinical trials in health care systems. ja.ma/4gviVNF



Honored to contribute to this consensus paper on alterations in the renin-angiotensin system and the use of exogenous angiotensin II in septic shock! Patrick Wieruszewski Matthieu Legrand Ashish K. Khanna, MD,MS,FCCP,FCCM,FASA Professor Katarzyna Kotfis, MD, PhD, EDAIC Marlies Ostermann Giovanni Landoni, MD Ricard Ferrer Marc Leone





#šššššššš ā šš”šš§š¤ ššØš®! An incredible few days of learning, collaboration & innovation! Huge thanks to our attendees, speakers & partnersāyour dedication is inspiring. The story continues⦠See you at #ISICEM26 or our next meetings! #ICUcommunity #ISICEMers

ISICARE - In response to numerous requests last week, weāve decided to extend this special offer for an additional week, until the end of the early bird rate, March 31! Register now & take advantage of this unique opportunity! isicare.org/12/Registratio⦠#ISICARE Filippo Annoni

Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users. What are the impart of SGLT2 inhibitors on postoperative outcomes? What are the risk of euglycemic keto-acidosis in patients treated with SGLT2 inhibitors and undergoing surgery? jamanetwork.com/journals/jamasā¦

